Illumina (NASDAQ:ILMN) Price Target Raised to $200.00

Illumina (NASDAQ:ILMN – Free Report) had its price objective increased by Leerink Partners from $160.00 to $200.00 in a research note published on Thursday, Benzinga reports. Leerink Partners currently has an outperform rating on the life sciences company’s stock. A number of other brokerages have also weighed in on ILMN. TD Cowen raised shares of […]

Leave a Reply

Your email address will not be published.

Previous post Citigroup (NYSE:C) Price Target Increased to $64.00 by Analysts at Evercore ISI
Next post Geron (NASDAQ:GERN) Receives New Coverage from Analysts at Scotiabank